Title : Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways.

Pub. Date : 2011 Apr 7

PMID : 21472003






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways. phenethyl isothiocyanate mitogen-activated protein kinase 8 Homo sapiens
2 Conversely, enforced activation of Akt by a constitutively active Akt construct markedly abrogated PEITC-mediated JNK activation, Mcl-1 downregulation, caspase activation, and apoptosis, and also interruption of the JNK pathway by pharmacological or genetically (e.g., siRNA) attenuated PEITC-induced apoptosis. phenethyl isothiocyanate mitogen-activated protein kinase 8 Homo sapiens
3 Conversely, enforced activation of Akt by a constitutively active Akt construct markedly abrogated PEITC-mediated JNK activation, Mcl-1 downregulation, caspase activation, and apoptosis, and also interruption of the JNK pathway by pharmacological or genetically (e.g., siRNA) attenuated PEITC-induced apoptosis. phenethyl isothiocyanate mitogen-activated protein kinase 8 Homo sapiens
4 Finally, administration of PEITC markedly inhibited tumor growth and induced apoptosis in U937 xenograft model in association with inactivation of Akt, activation of JNK, as well as downregulation of Mcl-1. phenethyl isothiocyanate mitogen-activated protein kinase 8 Homo sapiens
5 Taken together, these findings represent a novel mechanism by which agents targeting Akt/JNK/Mcl-1 pathway potentiate PEITC lethality in transformed and primary human leukemia cells and inhibitory activity of tumor growth of U937 xenograft model. phenethyl isothiocyanate mitogen-activated protein kinase 8 Homo sapiens